Erlotinib and dysphagia Patient Reports February 11, 2012

Erlotinib Side Effects Report #5587758-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 24, 2007. Male patient, 63 years of age, was diagnosed with tonsil cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: aspiration, dysphagia, hyporeflexia, pneumonia

, radiation dysphagia. Erlotinib dosage: (150 MG). During the same period patient was treated with BEVACIZUMAB, TAXOL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5677828-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Mar 04, 2008. Male patient, 63 years of age, weighting 147.0 lb, was diagnosed with tonsil cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: areflexia, aspiration, bronchial secretion retention, dysphagia, ejection fraction decreased, laryngitis, mucosal inflammation, pneumonia

, saliva altered. Erlotinib dosage: 150 MG. During the same period patient was treated with BEVACIZUMAB, TAXOL, CARBOPLATIN, FLUOROURACIL, LORTAB, PLAVIX, INHALER, KLONOPIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5055970-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 07, 2006. Male patient, 48 years of age, was diagnosed with tonsil cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood chloride decreased, blood sodium decreased, candidiasis, decreased appetite, dehydration, dysphagia, malaise, mucosal inflammation. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, CISPLATIN, AUGMENTIN, NYSTATIN, DURAGESIC. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5098898-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 17, 2006. Female patient, 56 years of age, weighting 182.0 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anxiety

, dehydration, diarrhoea, dizziness

, dysphagia, epistaxis, hypoaesthesia, hypoglycaemia, mouth haemorrhage. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with ZANTAC, INDERAL LA, GLUCOPHAGE, MIRAPEX, LOPID, GLIPIZIDE, FISH OIL, WELLBUTRIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5345309-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on May 17, 2007. Female patient, 55 years of age, weighting 158.1 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, oral discomfort, pyrexia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL, FLUOROURACIL, RADIATION. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5371423-1
Erlotinib side effect was reported by a Health Professional from UNITED STATES on June 07, 2007. Female patient, 55 years of age, weighting 158.1 lb, was diagnosed with squamous cell carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, feeding disorder, hypertension, oral discomfort, pyrexia. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CARBOPLATIN, PACLITAXEL, FLUOROURACIL, RADIATION. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5822141-4
Erlotinib side effect was reported by a Physician from AUSTRIA on July 10, 2008. Female patient, 79 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, catheter site infection, dehydration, dysphagia, nervous system disorder, parkinsonism, performance status decreased, speech disorder, urticaria. Erlotinib dosage: 150 MG (150 MG, QD), ORAL; 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DIGIMERCK, PANTOPRAZOLE, LASIX, DURAGESIC, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5942619-2
Erlotinib side effect was reported by a Physician from AUSTRIA on Oct 17, 2008. Female patient, 79 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: asthenia, c-reactive protein increased, central line infection, dehydration, dysphagia, hypoglycaemia, parkinsonism, performance status decreased, progressive supranuclear palsy

. Erlotinib dosage: 150 MG (150 MG,QD), ORAL; 150 MG (QD), ORAL. During the same period patient was treated with CARBOPLATIN, PACLITAXEL, DIGIMERCK, PANTOPRAZOLE, LASIX, DURAGESIC, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5545516-X
Erlotinib side effect was reported by a Physician from BELGIUM on Dec 03, 2007. Female patient, 66 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, gastritis. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with XANAX, TRAZOLAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5598683-6
Erlotinib side effect was reported by a Physician from BELGIUM on Jan 02, 2008. Female patient, 66 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, endoscopy upper gastrointestinal tract abnormal. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with XANAX, TRAZOLAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5631784-2
Erlotinib side effect was reported by a Physician from BELGIUM on Jan 30, 2008. Female patient, 66 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebrovascular disorder, dysphagia, gastritis. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with XANAX, TRAZOLAN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5736885-6
Erlotinib side effect was reported by a Health Professional from BELGIUM on Apr 24, 2008. Female patient, 66 years of age, was diagnosed with ovarian cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cerebral disorder, dysphagia, gastritis, metastases to central nervous system, ovarian cancer metastatic. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with XANAX, TRAZOLAN, OMEPRAZOLE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5908423-6
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 15, 2008. Male patient, 66 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dysphagia, leukopenia, lip pain, mucosal inflammation, oesophagitis, oral pain. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, FLUOROURACIL, CARBOPLATIN, PACLITAXEL, OXYCODONE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6140496-0
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 17, 2009. Female patient, 65 years of age, weighting 138.9 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, dysphagia, mucosal inflammation, nausea

, white blood cell count decreased. Erlotinib dosage: (100 MG,QD),ORAL. During the same period patient was treated with BEVACIZUMAB, TAXOL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6063552-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 16, 2009. Male patient, 58 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, dysphagia, febrile neutropenia, penis disorder

, vomiting, white blood cell count decreased. Erlotinib dosage: unknown. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6083750-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 03, 2009. Male patient, 58 years of age, weighting 186.1 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, dehydration, diarrhoea, dysphagia, febrile neutropenia, penis disorder

, vomiting, white blood cell count decreased. Erlotinib dosage: 100 MG, DAYS 1-42, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL, ROXICET, DOXYCYCLINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5808286-3
Erlotinib side effect was reported by a Physician from UNITED STATES on June 24, 2008. Female patient, weighting 72.09 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood potassium decreased, dehydration, discomfort, dysphagia, failure to thrive, interstitial lung disease, pain

, pancytopenia. Erlotinib dosage: (100 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5819960-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 07, 2008. Female patient, weighting 72.09 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: abdominal pain upper, blood calcium decreased, blood potassium decreased, clostridium difficile colitis, dehydration, discomfort, dysphagia, failure to thrive. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5834179-1
Erlotinib side effect was reported by a Physician from UNITED STATES on July 16, 2008. Female patient, weighting 72.09 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood albumin decreased, blood calcium decreased, blood potassium decreased, clostridium difficile colitis, dehydration, discomfort, dysphagia, failure to thrive. Erlotinib dosage: (100 MG,QD) ,ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FLUOROURACIL. Patient was hospitalized. Patient died.

Erlotinib Side Effects Report #5808286-3
Erlotinib side effect was reported by a Physician from UNITED STATES on June 24, 2008. Female patient, weighting 72.09 lb, was diagnosed with oesophageal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood potassium decreased, dehydration, discomfort, dysphagia, failure to thrive, interstitial lung disease, pain

, odynophagia, oral intake reduced, weight decreased. Erlotinib dosage: 150 MG, QD, PO. During the same period patient was treated with BEVACIZUMAB, PROGRAF, MYFORTIC, PREVACID, LIPITOR, PREDNISONE, METOPROLOL SUCCINATE, ASPIRIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5251951-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 07, 2007. Male patient, 74 years of age, weighting 145.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bacterial infection

, bronchoscopy abnormal, dysphagia, necrosis, odynophagia, oesophagitis, oral intake reduced, sputum purulent. Erlotinib dosage: 150 MG (QD), ORAL. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5374082-7
Erlotinib side effect was reported by a Physician from UNITED STATES on June 12, 2007. Female patient, 72 years of age, weighting 121.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, dysphagia, fatigue, hydropneumothorax, hypoxia, lung neoplasm, mucosal exfoliation, mucosal inflammation, oesophageal stenosis. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with MUPIROCIN CREAM, NORVASC, ENALAPRIL, SYNTHROID, SYSTANE, BENZOCAINE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5323622-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 23, 2007. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: coagulation factor v level increased, coagulation factor viii level increased, dysphagia, haemoptysis, oesophagitis, oral intake reduced, prothrombin level increased, prothrombin time prolonged, vitamin k deficiency. Erlotinib dosage: 100 MG (QD) , ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FENTANYL CITRATE, LIDOCAINE, ZOLPIDEM TARTRATE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6032157-3
Erlotinib side effect was reported by a Physician from SWITZERLAND on Dec 23, 2008. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: disease progression, dysphagia, lymphoedema. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIAUMAB, GEMZAR, CARBOPLATIN, METAMIZOLE, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #4781644-4
Erlotinib side effect was reported by a Physician from GERMANY on Sept 12, 2005. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, malignant neoplasm progression, metastases to lung, non-small cell lung cancer, rash

, vision blurred, visual disturbance. Erlotinib dosage: 100 MG (QD), ORAL. During the same period patient was treated with SPIRONOLACTONE, FUROSEMIDE, ACETYLCYSTEINE, ASPIRIN, PREDNISONE, ALBUTEROL SULPHATE, ZOMETA. Patient was hospitalized and became disabled. Patient recovered.

Erlotinib Side Effects Report #4851118-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 01, 2005. Female patient, 67 years of age, weighting 173.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bacterial infection

, dilatation atrial, dysphagia, lymphangitis, malignant neoplasm progression, non-small cell lung cancer stage iv, pleural effusion, pulmonary hypertension

, sputum culture positive. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN, PREDNISONE, COMBIVENT, NORVASC. Patient was hospitalized and became disabled. Patient died on 11/18/2005.

Erlotinib Side Effects Report #5924656-7
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Oct 02, 2008. Male patient, 59 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, candidiasis, chronic obstructive pulmonary disease, cough, dehydration, dysphagia, electrolyte imbalance, gait disturbance, mental status changes. Erlotinib dosage: (50 MG), ORAL. During the same period patient was treated with SORAFENIB, PANTOPRAZOLE, ANESTHETIC MOUTH WASH, OXYCODONE WITH APAP, ENOXAPARIN SQ, ZOFRAN IV PM, LORAZEPAM IV PM, POTASSIUM SUPPLEMENT. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5955949-5
Erlotinib side effect was reported by a Physician from UNITED STATES on Oct 27, 2008. Male patient, 59 years of age, weighting 108.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anorexia, asthenia, candidiasis, confusional state, cough, dehydration, dysphagia, electrolyte imbalance, mental status changes. Erlotinib dosage: (50 MG, QD), ORAL. During the same period patient was treated with SORAFENIB, PANTOPRAZOLE, ANESTHETIC MOUTH WASH, OXYCODONE WITH APAP, ENOXAPARIN SQ, ZOFRAN IV PM, LORAZEPAM IV PM. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5588179-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Dec 24, 2007. Male patient, 37 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with PARACETAMOL, DOXYCYCLINE, DEXAMETHASONE. Patient recovered.

Erlotinib Side Effects Report #5215813-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Jan 12, 2007. Male patient, 53 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood sodium decreased, candidiasis, dysphagia, haemoglobin decreased, hiccups, mucosal inflammation, odynophagia, pharyngolaryngeal pain, pyrexia. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with AVASTIN, CISPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5122455-X
Erlotinib side effect was reported by a Physician from UNITED STATES on Sept 25, 2006. Male patient, 47 years of age, weighting 149.9 lb, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, odynophagia, oral intake reduced, parotitis, radiation injury. Erlotinib dosage: unknown. During the same period patient was treated with AVASTIN, CISPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5060015-X
Erlotinib side effect was reported by a Health Professional from UNITED STATES on July 12, 2006. Male patient, 44 years of age, was diagnosed with neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, mucosal inflammation, weight decreased. Erlotinib dosage: 100 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, CISPLATIN. Patient recovered.

Erlotinib Side Effects Report #5442832-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Aug 28, 2007. Female patient, 79 years of age, weighting 101.0 lb, was diagnosed with metastatic neoplasm, neoplasm malignant and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dehydration, diarrhoea, dysphagia, dyspnoea, vomiting. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5800759-2
Erlotinib side effect was reported by a Physician from SPAIN on June 19, 2008. Female patient, 50 years of age, was diagnosed with head and neck cancer

and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, food intolerance, mucosal inflammation, skin inflammation, vomiting. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with CISPLATIN, DICLOFENAC, FENTANILO, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #6099451-1
Erlotinib side effect was reported by a Health Professional from SPAIN on Feb 12, 2009. Female patient, 50 years of age, was diagnosed with head and neck cancer

and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dermatitis, dysphagia, food intolerance, mucosal inflammation, vomiting. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with CISPLATIN, DICLOFENAC, FENTANILO, CITALOPRAM HYDROBROMIDE. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5243835-8
Erlotinib side effect was reported by a Physician from DENMARK on Jan 31, 2007. Female patient, 46 years of age, was diagnosed with gastrointestinal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, erosive oesophagitis, malignant neoplasm progression, metastases to lung, oesophageal cancer metastatic, oesophagobronchial fistula. Erlotinib dosage: 150 MG (QD); ORAL. During the same period patient was treated with BEVACIZUMAB, LYRICA, PRIMPERAN, LACTULOSE, ACTILAX, PREDNISOLONE, LORAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Erlotinib Side Effects Report #5270340-5
Erlotinib side effect was reported by a Physician from DENMARK on Feb 27, 2007. Female patient, 46 years of age, was diagnosed with gastrointestinal carcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: dysphagia, oesophagobronchial fistula. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB, LYRICA, PRIMPERAN, LACTULOSE, ACTILAX, PREDNISOLONE, LORAZEPAM, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Erlotinib and dysphagia

SideEffects101.com

Erlotinib and dysphagia Patient Reports February 11, 2012

side effects of Erlotinib